Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies
Introduction The U.S. Food and Drug Administration (FDA) provides regulatory guidance to ensure the development and evaluation of safe and effective drugs and biologics.…
Read more →Clarification of Radiation Control Regulations For Manufacturers of Diagnostic X-Ray Equipment
Introduction Navigating the regulatory landscape of drug and biologic approvals in the United States requires clear communication between sponsors and the U.S. Food and…
Read more →Conducting Clinical Trials With Decentralized Elements
Conducting Clinical Trials With Decentralized Elements Introduction The U.S. Food and Drug Administration (FDA) plays a critical role in ensuring the quality, safety, and…
Read more →Technical Specifications for Submitting Clinical Trial Data Sets for Treatment of Noncirrhotic Nonalcoholic Steatohepatitis (NASH)
The U.S. Food and Drug Administration (FDA) plays a crucial role in ensuring drug safety and effectiveness. One of its key regulatory tools is…
Read more →Standardized Format for Electronic Submission of NDA and BLA Content for the Planning of Bioresearch Monitoring (BIMO) Inspections for CDER Submissions Guidance for Industry
Introduction The U.S. Food and Drug Administration (FDA) has established guidelines for adverse event reporting (AER) concerning dietary supplements to ensure consumer safety and…
Read more →Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products | Shudarsana Company
The U.S. Food and Drug Administration (FDA) has introduced new regulatory requirements for cosmetic product manufacturers under the Modernization of Cosmetics Regulation Act of…
Read more →